←
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE1,119 posts
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE avatar

Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE

@BettyKimLab

Surgeon Scientist, Professor, Brain Tumor Surgeon, NIH and DOD Funded, #TwinMum, #AIMBE, #ASCI @MDAndersonNews, #Nanomedicine, #immunotherapy. Views are my own

◷ Joined February 2016▧ 319 Photos and videos
UT MD Anderson avatar
⟳ Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE retweeted
UT MD Anderson@UTMDAnderson·11 Jul 2025

Congratulations to the 2025 Sabin Family Fellows — 10 early career researchers selected for their bold, high-impact cancer research. We thank the Sabin Family Fellowship for their continued support. spr.ly/60154Ibll #EndCancer

Post attachment
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE avatar
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE@BettyKimLab·6 Jun 2025

As we graduate our extraordinary fellows and residents, I am reminded of how little I knew when I thought I knew. From Highschool to Fellowship-Trained Neurosurgeon Scientist: 26 years.Thank you Mom, Dad, Wen, Hannah, teachers/mentors and our patients.

Post attachmentPost attachment
Kristin Huntoon avatar
⟳ Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE retweeted
Kristin Huntoon@KristinHuntoon·26 Mar 2025

So grateful for our team and looking forward to what more we can accomplished. Check out our newest manuscript how we target the #STING pathway by #microbubbles and #ultrasound @lux_jacques @BettyKimLab @YWangPhD @UAZNeurosurgery advanced.onlinelibrary.wiley…

OncoDaily avatar
⟳ Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE retweeted
OncoDaily@oncodaily·1 Mar 2025

Why do tumors evade immune detection, even when phagocytosed? - @BenjaminSchrank @BettyKimLab @MDAndersonNews @YWangPhD @DYLee_BME @AnnetteWu9 oncodaily.com/blog/benjamin-… #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

OncoDaily avatar
⟳ Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE retweeted
OncoDaily@oncodaily·28 Feb 2025

The University of Texas MD Anderson Cancer Center researchers develop novel antibody-toxin conjugate @MDAndersonNews @BenjaminSchrank @BettyKimLab Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors. 🧬 According to preclinical results published today in Nature Cancer, the new approach combined the benefits of more well-known antibody-drug conjugates (ADCs) with those of immunotherapies💊 oncodaily.com/science/the-un… #Cancer #CancerResearch #CancerTreatment #MedEd #MedNews #MedX #Medicine #Health #Oncology #OncoDaily

Post attachment
OncoDaily avatar
⟳ Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE retweeted
OncoDaily@oncodaily·28 Feb 2025

We would like to inform you that your post has been published on OncoDaily.com. Thank you for sharing such valuable content. oncodaily.com/blog/benjamin-…

UT MD Anderson avatar
⟳ Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE retweeted
UT MD Anderson@UTMDAnderson·25 Feb 2025

MD Anderson researchers have developed a novel antibody toxin-conjugate that’s not designed to kill the cancer cells directly. Read how this new approach is designed to trigger the body's natural immune response instead: brnw.ch/21wQWWK #EndCancer